These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease. Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456 [TBL] [Abstract][Full Text] [Related]
3. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Ozkul Y; Evereklioglu C; Borlu M; Taheri S; Calis M; Dündar M; Ilhan O Br J Ophthalmol; 2005 Dec; 89(12):1634-7. PubMed ID: 16299146 [TBL] [Abstract][Full Text] [Related]
4. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675 [TBL] [Abstract][Full Text] [Related]
5. A unique case of thrombosis in Behçet's disease with methylene tetrahydrofolate reductase homozygous polymorphism and raised homocysteine levels. Vasudevan B; Verma R; Pragasam V; Malik A; Venugopal R; Gopal M Indian J Dermatol Venereol Leprol; 2013; 79(4):531-3. PubMed ID: 23760328 [No Abstract] [Full Text] [Related]
6. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis. Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176 [TBL] [Abstract][Full Text] [Related]
7. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population. Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS Blood Coagul Fibrinolysis; 2015 Dec; 26(8):869-73. PubMed ID: 26083986 [TBL] [Abstract][Full Text] [Related]
8. Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behçet's disease patients. Koubaa N; Hammami S; Nakbi A; Ben Hamda K; Mahjoub S; Kosaka T; Hammami M Clin Chem Lab Med; 2008; 46(2):187-92. PubMed ID: 18076365 [TBL] [Abstract][Full Text] [Related]
10. [Hyperhomocysteinemia and deep-vein thrombosis]. Qiu L; Yan SK; Song YH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):706-9. PubMed ID: 14714317 [TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet's disease. Düzgün N; Duman T; Morris Y; Tutkak H; Köse K; Ertuğrul E; Aydintuğ OT Clin Rheumatol; 2008 Oct; 27(10):1221-5. PubMed ID: 18458991 [TBL] [Abstract][Full Text] [Related]
12. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345 [TBL] [Abstract][Full Text] [Related]
13. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis. Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001 [TBL] [Abstract][Full Text] [Related]
14. Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion. Kim NK; Choi YK; Kang MS; Choi DH; Cha SH; An MO; Lee S; Jeung M; Ko JJ; Oh D Thromb Res; 2006; 117(6):653-8. PubMed ID: 15985285 [TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients. Vuckovic BA; Cabarkapa VS; Ilic TA; Salatic IR; Lozanov-Crvenkovic ZS; Mitic GP Croat Med J; 2013 Oct; 54(5):480-8. PubMed ID: 24170727 [TBL] [Abstract][Full Text] [Related]
17. [Study on the association of polymorphisms in homocysteine metabolism related enzymes with deep venous thrombosis]. Yu HD; Zheng H; Qi H; Lian JH; He Y; Dong ZM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):635-9. PubMed ID: 17160942 [TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet's disease. Feki M; Houman H; Ghannouchi M; Smiti-Khanfir M; Hamzaoui K; El Matri L; Mebazaa A; Kaabachi N Clin Chem Lab Med; 2004; 42(12):1417-23. PubMed ID: 15576305 [TBL] [Abstract][Full Text] [Related]
20. [A common mutation C677T in the 5,10-methyltetrahydrofolate reductase gene is associated to idiopathic deep venous thrombosis]. Berrut G; Ghali A; Quere I; Ternisien C; Gallois I; Roy PM; Marre M; Fressinaud P Rev Med Interne; 2003 Sep; 24(9):569-76. PubMed ID: 12951177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]